OraSure Technologies (OSUR) Proxy Filing summary

Executive summary

• Altai Capital intends to nominate two candidates, including its founder, for election to the board at the 2026 annual meeting.

• The board has recently refreshed its composition, adding three independent directors and appointing a new chair in October 2025.

• Strategic initiatives include advancing the innovation roadmap, consolidating operations, and launching new diagnostic products.

• A $40 million share repurchase program was initiated, and key executives adopted Rule 10b5-1 trading plans for stock purchases.

• The company maintains a strong cash position with $216 million and no debt as of September 30, 2025.

Voting matters and shareholder proposals

• Shareholders are informed of Altai Capital's intent to nominate directors, but no action is required at this time.

• Upon formal nominations, the board will review and provide recommendations to shareholders.

Board of directors and corporate governance

• The board has undergone significant refreshment, with seven departures and three new independent directors added in the past three years.

• John P. Kenny was appointed as board chair in October 2025.

• The board emphasizes independence and engagement, with ongoing assessment of its composition.